The goal of this prospective, observational study is to learn about the pathogenesis and biological target of the subtypes of poor ovarian response (POR) during In vitro fertilization and embryo transfer (IVF-ET). The main question it aims to answer is: 1. Can the relative expression level of SIRT3 differentiate between POR subtypes, and do these differences reflect distinct metabolic characteristics among the subtypes? 2. Investigate whether SIRT3 expression levels correlate with clinical outcomes. This study will enroll patients with various POR subtypes and collect discarded follicular fluid and granulosa cells on the day of egg retrieval. IVF outcome information routinely collected in electronic databases will also be recorded. Notably, this is a purely observational study with no additional interventions. Your participation will not alter your clinical treatment compared to other patients.
Study Type
OBSERVATIONAL
Enrollment
80
Not applicable- observational study
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Jinan, Shandong, China
The relative expression level of SIRT3 mRNA of granulosa cells
The real-time quantitative PCR methods were used to test the relative expression level of SIRT3 mRNA of granulosa cells of each participant among groups.
Time frame: Detected within three days after oocyte retrieval
Positive pregnancy rate
Serum β-hCG level ≥ 10mIU/mL, 14 days after embryo transfer. \[Detected via ELISA\]
Time frame: 2 weeks after the day of embryo transfer
Embryo implantation rate
The number of intrauterine gestational sacs observed divided by the number of embryos transferred. \[Detected via ultrasound\]
Time frame: 3 weeks after the day of embryo transfer
Clinical pregnancy rate
An intrauterine gestational sac with fetal heartbeat detected by transvaginal ultrasonography. \[Detected via ultrasound\]
Time frame: 4 weeks after the day of embryo transfer
Number of oocytes retrieved
The total number of oocytes retrieved in the In Vitro Fertilization and Embryo transfer cycle.
Time frame: Within 1 day after the oocyte retrieval
Average daily dose of gonadotropin per COS cycle
Average daily dose of gonadotropin per COS cycle
Time frame: Through the process of controlled ovarian stimulation, an average of 10 days
Total dosage of gonadotropin per COS cycle
Total dosage of gonadotropin per COS cycle
Time frame: Through the process of controlled ovarian stimulation, an average of 10 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.